A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells

References

• Guillaumond F, Iovanna JL, Vasseur S. Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways. Arch Biochem Biophys 2014; 545:69-73; PMID:24393743; http://dx.doi.org/10.1016/j.abb.2013.12.019
   PubMed Web of Science ®Google Scholar
• Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 2006; 66:10525-33; PMID:17079475; http://dx.doi.org/10.1158/0008-5472.CAN-06-2387
   PubMed Web of Science ®Google Scholar
• Saiki Y, Horii A. Molecular pathology of pancreatic cancer. Pathol Int 2014; 64:10-9; PMID:24471965; http://dx.doi.org/10.1111/pin.12114
   PubMed Web of Science ®Google Scholar
• Preis M, Korc M. Signaling pathways in pancreatic cancer. Crit Rev Eukar Gene Exp 2011; 21:115-29; PMID:22077151; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v21.i2.20
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 2009; 15:1163-9; PMID:19734908; http://dx.doi.org/10.1038/nm.2009
   PubMed Web of Science ®Google Scholar
• Sheta EA, Harding MA, Conaway MR, Theodorescu D. Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor. J Nat Cancer Inst 2000; 92:1065-73; PMID:10880549; http://dx.doi.org/10.1093/jnci/92.13.1065
   PubMedGoogle Scholar
• Liu W, Bloom DA, Cance WG, Kurenova EV, Golubovskaya VM, Hochwald SN. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis 2008; 29:1096-107; PMID:18263593; http://dx.doi.org/10.1093/carcin/bgn026
   PubMed Web of Science ®Google Scholar
• Ucar DA, Kurenova E, Garrett TJ, Cance WG, Nyberg C, Cox A, Massoll N, Ostrov DA, Lawrence N, Sebti SM, et al. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Cell Cycle 2012; 11:3250-9; PMID:22894899; http://dx.doi.org/10.4161/cc.21611
   PubMed Web of Science ®Google Scholar
• Hochwald SN, Nyberg C, Zheng M, Zheng D, Wood C, Massoll NA, Magis A, Ostrov D, Cance WG, Golubovskaya VM. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle 2009; 8:2435-43; PMID:19571674; http://dx.doi.org/10.4161/cc.8.15.9145
   PubMed Web of Science ®Google Scholar
• Ucar DA, Dang LH, Hochwald SN. Focal adhesion kinase signaling and function in pancreatic cancer. Front Biosci (Elite Ed) 2011; 3:750-6; PMID:21196348; http://dx.doi.org/10.2741/e283
   PubMedGoogle Scholar
• Zhang J, Hochwald SN. The role of FAK in tumor metabolism and therapy. Pharmacol Ther 2014; 142:154-63; PMID:24333503; http://dx.doi.org/10.1016/j.pharmthera.2013.12.003
   PubMed Web of Science ®Google Scholar
• Schultze A, Fiedler W. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase. Anti-Cancer Agent Med Chem 2011; 11:593-9; PMID:21787277; http://dx.doi.org/10.2174/187152011796817727
   PubMed Web of Science ®Google Scholar
• Soria J-C, Arkenau H-T, Blagden SP, Plummer R, Ranson M, Evans TRJ, Zalcman G, Bahleda R, Hollebecque A, Lemech Cet al, . Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors. J Clin Oncol: Off J Am Soc Clin Oncol 2012; 30: abstr 3000
   Google Scholar
• Auger KR, Smitheman KN, Korenchuk S, McHugh C, Kruger R, Aller GSV, Smallwood A, Gontarek RR, Faitg T, Johnson N. The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer. Eur J Cancer 2012; 48:118; http://dx.doi.org/10.1016/S0959-8049(12)72185-8
   Web of Science ®Google Scholar
• Lai IR, Chu PY, Lin HS, Liou JY, Jan YJ, Lee JC, Shen TL. Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance. Am J Pathol 2010; 177:1629-37; PMID:20724588; http://dx.doi.org/10.2353/ajpath.2010.100172
   PubMed Web of Science ®Google Scholar
• Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer J Int Du Cancer 1977; 19:128-35; PMID:832918; http://dx.doi.org/10.1002/ijc.2910190118
   PubMed Web of Science ®Google Scholar
• Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer J Int Du Cancer 1975; 15:741-7; PMID:1140870; http://dx.doi.org/10.1002/ijc.2910150505
   PubMed Web of Science ®Google Scholar
• Owens RB, Smith HS, Nelson-Rees WA, Springer EL. Epithelial cell cultures from normal and cancerous human tissues. J Nat Cancer Inst 1976; 56:843-9; PMID:176412
   PubMed Web of Science ®Google Scholar
• Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, Berjian R, Douglass HO, Martin EW, Chu TM. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In vitro 1982; 18:24-34; PMID:7182348; http://dx.doi.org/10.1007/BF02796382
   PubMedGoogle Scholar
• Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1999; 1:50-62; PMID:10935470; http://dx.doi.org/10.1038/sj.neo.7900005
   PubMedGoogle Scholar
• Loor R, Nowak NJ, Manzo ML, Douglass HO, Chu TM. Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer. Clin Lab Med 1982; 2:567-78; PMID:6754226
   PubMedGoogle Scholar